Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrases (CAs) are metalloenzymes that catalyze the reversible hydration of carbon dioxide. In *Schistosoma mansoni*, a parasitic blood fluke responsible for intestinal schistosomiasis, two classes of CAs have been identified: an α-class CA (SmCA) and a β-class CA (SmaBCA). These enzymes are essential for parasite survival and infectivity. SmCA is highly expressed in the tegument of *S. mansoni* and contributes to pH regulation, ion transport, and evasion of host immune responses. Inhibition of SmCA and SmaBCA is a promising therapeutic strategy for schistosomiasis.
Enzyme inhibition; Competitive inhibition of carbonic anhydrase activity
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase from Schistosoma mansoni (SmCA/SmaBCA).